Sign In

Michael Ehlers

Scientist, R&D Leader, Biotech Entrepreneur

Michael Ehlers is an experienced R&D leader, accomplished scientist, and biotech entrepreneur with a strong background in innovation, organizational leadership, and therapeutic development in the biotechnology and pharmaceutical sectors. He pursued MD, PhD, Medicine, Neuroscience at The Johns Hopkins University School of Medicine. Michael has held key positions such as Chief Scientific Officer and Venture Partner at Apple Tree Partners, President & Executive Chair at Aulos Bioscience, Chief Executive Officer at Limelight Bio & Affiliates, and various senior roles at Pfizer including Executive Vice President, Group Senior Vice President, Senior Vice President, and Chief Scientific Officer for Neuroscience. Additionally, he has served as a Professor of Neurobiology at Duke University.

Highlights

Jan 29 · linkedin

Ascidian announced today that we received IND clearance for ACDN-01, the first-ever RNA exon editing candidate.  I invite you to read my article on what this milestone means for Stargardt disease patients, Ascidian, and the field of gene editing medicines. #RNAExonEditing https://lnkd.in/eCVWGiJX

Jan 29 · linkedin
M
Add to my network

Location

Cambridge, Massachusetts